Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3Classical hematology 2Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 146Endometrial Neoplasms 89Uterine Cervical Neoplasms 75Breast Neoplasms 44Fallopian Tube Neoplasms 39Colorectal Neoplasms 35Carcinoma, Non-Small-Cell Lung 34Pancreatic Neoplasms 25Neoplasms 25Prostatic Neoplasms 22Neoplasm Metastasis 21Stomach Neoplasms 19Triple Negative Breast Neoplasms 18Urinary Bladder Neoplasms 17Esophageal Neoplasms 17Melanoma 16Lung Neoplasms 16Carcinoma, Renal Cell 16Squamous Cell Carcinoma of Head and Neck 15Head and Neck Neoplasms 15Carcinoma, Ovarian Epithelial 15Carcinoma, Hepatocellular 14Sarcoma 13Cholangiocarcinoma 13Carcinoma, Transitional Cell 12Uterine Neoplasms 11Colonic Neoplasms 11Small Cell Lung Carcinoma 10Rectal Neoplasms 10Vulvar Neoplasms 9

Interventions

Tretinoin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Gynecologic × 30 days × Clear all
NCT07586826 2026-05-14

N01-A-PICIT-GT

Peking University People's Hospital

Phase 2 Recruiting
220 enrolled
BreastClassical hematologyGynecologicThoracic

Pathologic Complete Response, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thrombocytopenia, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡